Variant position: 304 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 371 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human CRNPDCWGVRGQFCGPCLRN RYGEEVRDALLDPNWHCPPCR
Mouse CRNPDCWGIRGQFCGPCLRN RYGEEVKDALLDPNWHCPPCR
Rat CRNPDCWGIRGQFCGPCLRN RYGEEVKDALLDPNWHCPPCR
Bovine CRNPECWGVRGQFCGPCLRN RYGEEVKDALLDPNWHCPPCR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 371 Cell division cycle-associated protein 7
247 – 371 Mediates transcriptional activity
208 – 371 Missing. In isoform 4.
267 – 316 Missing. In isoform 3.
Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.
Thijssen P.E.; Ito Y.; Grillo G.; Wang J.; Velasco G.; Nitta H.; Unoki M.; Yoshihara M.; Suyama M.; Sun Y.; Lemmers R.J.; de Greef J.C.; Gennery A.; Picco P.; Kloeckener-Gruissem B.; Guengoer T.; Reisli I.; Picard C.; Kebaili K.; Roquelaure B.; Iwai T.; Kondo I.; Kubota T.; van Ostaijen-Ten Dam M.M.; van Tol M.J.; Weemaes C.; Francastel C.; van der Maarel S.M.; Sasaki H.;
Nat. Commun. 6:7870-7870(2015)
Cited for: INVOLVEMENT IN ICF3; VARIANTS ICF3 CYS-274; HIS-274; VAL-294 AND HIS-304;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.